News & Events

January New Hires and Promotions

January 18, 2018

CTI is pleased to welcome all new employees who have recently joined the CTI team, and to congratulate employees on their recent promotions! Matt Hodskins promoted to Director, Business Development, Consulting Operations Dr. Robert Gaston joins as Medical Director Nicole Dalessandro promoted to Senior Study Coordinator Stacey France joins ...

Read More

CTI Clinical Trial & Consulting Services Announces Dr. Robert Gaston has joined as Medical Director

January 17, 2018

CTI Clinical Trial & Consulting Services Announces Dr. Robert Gaston has joined as Medical Director FOR IMMEDIATE RELEASE [Covington, KY ~ January 10, 2018] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to welcome Dr. Robert Gaston as he joins the ...

Read More

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

December 7, 2017

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials FOR IMMEDIATE RELEASE [Covington, KY ~ December 7, 2017] CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of ...

Read More

CTI Clinical Trial & Consulting Services Welcomes and Announces Promotions of Directors of Regulatory Affairs and Real World Evidence & Late Phase Research

November 28, 2017

CTI Clinical Trial & Consulting Services Welcomes and Announces Promotions of Directors of Regulatory Affairs and Real World Evidence & Late Phase Research FOR IMMEDIATE RELEASE [Covington, KY ~ November28, 2017] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to welcome ...

Read More

Bexion Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of BXQ-350 in Patients with Advanced Solid Tumors

November 6, 2017

Bexion Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of BXQ-350 in Patients with Advanced Solid Tumors FOR IMMEDIATE RELEASE [Covington, KY ~ November 1, 2017] Bexion Pharmaceuticals, Inc. (Bexion) announces the start of a Phase 1b study of BXQ-350, an open-label study in adult patients with advanced solid ...

Read More

Join Our Mailing List